CD3-depleted hematopoietic stem cell graft
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD3-depleted hematopoietic stem cell graft, covering 2026-01-26 to 2026-01-26. Get the full timeline:
Most recent: Clinical Trial Update: Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies [Phase 2, Phase 3]